Mario Ynga-Durand

6PUBLICATIONS
27CO-AUTHORS
Infectious diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Environmental epidemiologyImmunogenetics (incl. genetic immunology)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 25, 2021
Erratum to "Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome".

Cesar Daniel Alonso-Bello, María Del Carmen Jiménez-Martínez, María Eugenia Vargas-Camaño

|May 29, 2020
Functional role of kallikrein 5 and proteinase-activated receptor 2 in eosinophilic esophagitis.

Nurit P Azouz, Andrea M Klingler, Purnima Pathre

|Jul 30, 2019
Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome.

Cesar Daniel Alonso-Bello, María Del Carmen Jiménez-Martínez, María Eugenia Vargas-Camaño

|Jul 26, 2019
Dialyzable Leukocyte Extract (Transferon™) Administration in Sepsis: Experience from a Single Referral Pediatric Intensive Care Unit.

Maria Isabel Castrejón Vázquez, Aldo Arturo Reséndiz-Albor, Mario A Ynga-Durand

|Jun 08, 2018
The antiprotease SPINK7 serves as an inhibitory checkpoint for esophageal epithelial inflammatory responses.

Nurit P Azouz, Mario A Ynga-Durand, Julie M Caldwell

Pageof 1